Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc. financial statements

Odyssey Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 2.98MEODHD
Net income−USD 148.65MEODHD
Cash and equivalentsUSD 41.69MEODHD
Total debtUSD 27.11MEODHD

Odyssey Therapeutics, Inc. financials on 6ix · Odyssey Therapeutics, Inc. on 6ix